First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study

Keyphrases

• China 100%
• 1-year Outcome 100%
• Drug-eluting Stent 100%
• Zilver PTX 100%
• China Studies 100%
• Superficial Femoral Artery 50%
• Arterial Lesions 50%
• Adverse Events 33%
• Chinese Patients 33%
• Ankle-brachial Index 33%
• Event-free Survival 33%
• Primary Patency 33%
• Target Lesion Revascularization 33%
• Lesion Length 33%
• Rutherford Classification 33%
• Walking Impairment Questionnaire 33%
• Clinical Outcomes 16%
• Short-term Outcomes 16%
• Unique Identifier 16%
• Patient Demographics 16%
• Paclitaxel 16%
• Amputation 16%
• Covariate Analysis 16%
• Clinical Improvement 16%
• Patency 16%
• Peripheral Arterial Disease 16%
• Duplex Ultrasound 16%
• Femoropopliteal Lesions 16%
• Multicenter Cohort Study 16%
• Total Occlusion 16%
• Pre-procedure 16%

Medicine and Dentistry

• Drug-Eluting Stent 100%
• Superficial Femoral Artery 50%
• Artery Lesion 50%
• Adverse Event 33%
• Ankle Brachial Index 33%
• Event Free Survival 33%
• Target Lesion Revascularization 33%
• Clinical Study 16%
• Patient Population 16%
• Paclitaxel 16%
• Amputation 16%
• Arteriosclerosis Obliterans 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Artery Lesion 100%
• Adverse Event 66%
• Event Free Survival 66%
• Clinical Study 33%
• Paclitaxel 33%
• Peripheral Occlusive Artery Disease 33%